Sequent Scientific Ltd.

NSE: SEQUENT | BSE: 512529 | ISIN: INE807F01027 | Industry: Pharmaceuticals
| Mid-range Performer
185.8900 0.58 (0.31%)
NSE Jul 03, 2025 15:31 PM
Volume: 294.6K
 

185.89
0.31%

Demerger of the Human API Business into Solara Active Pharma Sciences Limited which will
also house the Commodity API Business of Strides Shasun Limited, will help achieve critical
scale & size and emerge as one of the largest API companies from India. This decision, to part
with the business from Sequent was taken considering the dynamic regulatory landscape in
API industry along with the growing opportunities for a pure-play API player from India. The
demerger awaits the final nod from the National Company Law Tribunal, Mumbai, and will
be value accretive for its shareholder.

Rudra Shares and Stock Brokers Ltd
Sequent Scientific Ltd. is trading above its 200 day SMA of 175.3
More from Sequent Scientifi…
All earning calls
Investor presentations from Sequent Scientifi…
All investor presentations